Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Public ClinicalTrials.gov record NCT07661056. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Double-blind, Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of BHV-1300 in the Treatment of Adults With Graves' Disease
Study identification
- NCT ID
- NCT07661056
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Biohaven Therapeutics Ltd.
- Industry
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Interventions
- BHV-1300 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 25, 2026
- Primary completion
- Dec 31, 2027
- Completion
- Jan 31, 2028
- Last update posted
- Jul 19, 2026
2026 – 2028
United States locations
- U.S. sites
- 20
- U.S. states
- 10
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site-032 | Burbank | California | 91501 | Recruiting |
| Site-006 | San Diego | California | 92108 | Recruiting |
| Site-067 | Walnut Creek | California | 94598 | Recruiting |
| Site-052 | Doral | Florida | 33172 | Recruiting |
| Site-019 | Hialeah | Florida | 33016 | Recruiting |
| Site-025 | Lenexa | Kansas | 66234 | Recruiting |
| Site-072 | Las Vegas | Nevada | 89148 | Recruiting |
| Site-038 | Asheville | North Carolina | 28803 | Recruiting |
| Site-064 | Morehead City | North Carolina | 28557 | Recruiting |
| Site-033 | Statesville | North Carolina | 28625 | Recruiting |
| Site-045 | Wilmington | North Carolina | 28405 | Recruiting |
| Site-008 | Canton | Ohio | 44718 | Recruiting |
| Site-055 | Dallas | Texas | 75231 | Recruiting |
| Site-043 | Denton | Texas | 76210 | Recruiting |
| Site-042 | El Paso | Texas | 79935 | Recruiting |
| Site-071 | Houston | Texas | 77058 | Recruiting |
| Site-054 | McKinney | Texas | 75069 | Recruiting |
| Site-013 | Layton | Utah | 84041 | Recruiting |
| Site-073 | Midlothian | Virginia | 23112 | Recruiting |
| Site-076 | Seattle | Washington | 98104 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07661056, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 19, 2026 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07661056 live on ClinicalTrials.gov.